A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Clinical trial NCT02601287 · COMPLETED

Trial details

NCT number: NCT02601287
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Urinary Incontinence Overactive Bladder

Start date: 2015-11-01
Primary completion: 2016-07-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.